Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus-a possible link to venous thrombosis?

Lupus

Volumn 21, Issue 13, 2012, Pages 1423-1432

  Lood, C ^a   Eriksson, S ^a   Gullstrand, B ^a   Jonsen A ^a   Sturfelt, G ^a   Truedsson, L ^a   Bengtsson, A A ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cardiovascular disease; complement; platelet; Systemic lupus erythematosus; venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CITRATE SODIUM; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; LUPUS ANTICOAGULANT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ANTIPHOSPHOLIPID ANTIBODY SYNDROME; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD ANALYSIS; CENTRIFUGATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE AGGREGATION; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; COMPLEMENT C1Q; COMPLEMENT C3D; COMPLEMENT C4B; COMPLEMENT PATHWAY, CLASSICAL; FEMALE; FLOW CYTOMETRY; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; RISK FACTORS; UP-REGULATION; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84867809391     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312457210     Document Type: Article

References (29)

1. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore). 1989 ; 68: 141-150
2. Koskenmies S, Vaarala O, Widen E, Kere J, Palosuo T, Julkunen H. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Scand J Rheumatol. 2004 ; 33: 246-252
3. Pierangeli SS, Vega-Ostertag M, Liu X, Girardi G. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome. Ann N Y Acad Sci. 2005 ; 1051: 413-420
4. Girardi G, Berman J, Redecha P, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest. 2003 ; 112: 1644-1654
5. Jönsson G, Sjöholm AG, Truedsson L, Bengtsson AA, Braconier JH, Sturfelt G. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. Rheumatology (Oxford). 2007 ; 46: 1133-1139
6. Lood C, Amisten S, Gullstrand B, et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood. 2010 ; 116: 1951-1957
7. Nagahama M, Nomura S, Ozaki Y, Yoshimura C, Kagawa H, Fukuhara S. Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity. 2001 ; 33: 85-94
8. Hamad OA, Ekdahl KN, Nilsson PH, et al. Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J Thromb Haemost. 2008 ; 6: 1413-1421
9. Hamad OA, Nilsson PH, Wouters D, Lambris JD, Ekdahl KN, Nilsson B. Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J Immunol. 2010 ; 184: 2686-2692
10. Mehta N, Uchino K, Fakhran S, et al. Platelet C4d is associated with acute ischemic stroke and stroke severity. Stroke. 2008 ; 39: 3236-3241
11. Navratil JS, Manzi S, Kao AH, et al. Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 670-674
12. Shanmugavelayudam SK, Rubenstein DA, Yin W. Effects of physiologically relevant dynamic shear stress on platelet complement activation. Platelets. 2011 ; 22: 602-610
13. Peerschke E, Yin W, Alpert D, Roubey R, Salmon J, Ghebrehiwet B. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies. Lupus. 2009 ; 18: 530-538
14. Larsson A, Egberg N, Lindahl TL. Platelet activation and binding of complement components to platelets induced by immune complexes. Platelets. 1994 ; 5: 149-155
15. Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med. 2005 ; 201: 871-879
16. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
17. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 ; 29: 288-291
18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
19. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol. 2001 ; 115: 451-459
20. Vega-Ostertag M, Harris EN, Pierangeli SS. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. Arthritis Rheum. 2004 ; 50: 2911-2919
21. Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun. 1994 ; 7: 335-348
22. Wiener HM, Vardinon N, Yust I. Platelet antibody binding and spontaneous aggregation in 21 lupus anticoagulant patients. Vox Sang. 1991 ; 61: 111-121
23. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem. 1988 ; 263: 18,205-18,212
24. Pereira J, Alfaro G, Goycoolea M, et al. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost. 2006 ; 95: 94-99
25. Skoglund C, Wetterö J, Skogh T, Sjöwall C, Tengvall P, Bengtsson T. C-reactive protein and C1q regulate platelet adhesion and activation on adsorbed immunoglobulin G and albumin. Immunol Cell Biol. 2008 ; 86: 466-474
26. Skaggs BJ, Hahn BH, McMahon M. Accelerated atherosclerosis in patients with SLE-mechanisms and management. Nat Rev Rheumatol. 2012 ; 8: 214-223
27. Inal JM, Hui KM, Miot S, et al. Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor. J Immunol. 2005 ; 174: 356-366
28. Hamad OA, Nilsson PH, Lasaosa M, et al. Contribution of chondroitin sulfate A to the binding of complement proteins to activated platelets. PLoS One. 2010 ; 5: e12889 - e12889
29. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood. 2003 ; 101: 157-162